OABI Q3 2023 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-20.7% YoY

Gross Profit

$633,00011.6% margin

Operating Income

-$20M-370.6% margin

Net Income

-$16M-287.3% margin

EPS (Diluted)

$-0.16

QoQ Revenue Growth

-21.1%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$392M

Total Liabilities

$67M

Stockholders' Equity

$325M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$7M	-20.7%
Gross Profit	$633,000	$2M	-73.7%
Operating Income	-$20M	-$15M	-34.3%
Net Income	-$16M	-$13M	-24.9%

Revenue Segments

Service

$3M87%

Royalty

$451,00013%